Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

Pre-vaccination immunity and immune responses to a cell culture-derived whole-virus H1N1 vaccine are similar to a seasonal influenza vaccine.

Ehrlich HJ, Müller M, Kollaritsch H, Pinl F, Schmitt B, Zeitlinger M, Loew-Baselli A, Kreil TR, Kistner O, Portsmouth D, Fritsch S, Maritsch F, Aichinger G, Pavlova BG, Barrett PN.

Vaccine. 2012 Jun 22;30(30):4543-51. doi: 10.1016/j.vaccine.2012.03.061. Epub 2012 Apr 1.

PMID:
22475864
2.

Safety and immunogenicity of two different doses of a Vero cell-derived, whole virus clade 2 H5N1 (A/Indonesia/05/2005) influenza vaccine.

Tambyah PA, Wilder-Smith A, Pavlova BG, Barrett PN, Oh HM, Hui DS, Yuen KY, Fritsch S, Aichinger G, Loew-Baselli A, van der Velden M, Maritsch F, Kistner O, Ehrlich HJ.

Vaccine. 2012 Jan 5;30(2):329-35. doi: 10.1016/j.vaccine.2011.10.088. Epub 2011 Nov 12.

PMID:
22080174
3.

Clinical evaluation to determine the appropriate paediatric formulation of a tick-borne encephalitis vaccine.

Pöllabauer EM, Fritsch S, Pavlova BG, Löw-Baselli A, Firth C, Koska M, Maritsch F, Barrett PN, Ehrlich HJ.

Vaccine. 2010 Jun 23;28(29):4558-65. doi: 10.1016/j.vaccine.2010.04.075. Epub 2010 May 7.

PMID:
20452432
4.

Comparison of immunogenicity and safety between two paediatric TBE vaccines.

Pöllabauer EM, Pavlova BG, Löw-Baselli A, Fritsch S, Prymula R, Angermayr R, Draxler W, Firth C, Bosman J, Valenta B, Harmacek P, Maritsch F, Barrett PN, Ehrlich HJ.

Vaccine. 2010 Jun 23;28(29):4680-5. doi: 10.1016/j.vaccine.2010.04.047. Epub 2010 Apr 28.

PMID:
20433803
5.

A cell culture (Vero)-derived H5N1 whole-virus vaccine induces cross-reactive memory responses.

Ehrlich HJ, Müller M, Fritsch S, Zeitlinger M, Berezuk G, Löw-Baselli A, van der Velden MV, Pöllabauer EM, Maritsch F, Pavlova BG, Tambyah PA, Oh HM, Montomoli E, Kistner O, Noel Barrett P.

J Infect Dis. 2009 Oct 1;200(7):1113-8. doi: 10.1086/605608.

PMID:
19712040
6.

A clinical trial of a whole-virus H5N1 vaccine derived from cell culture.

Ehrlich HJ, Müller M, Oh HM, Tambyah PA, Joukhadar C, Montomoli E, Fisher D, Berezuk G, Fritsch S, Löw-Baselli A, Vartian N, Bobrovsky R, Pavlova BG, Pöllabauer EM, Kistner O, Barrett PN; Baxter H5N1 Pandemic Influenza Vaccine Clinical Study Team.

N Engl J Med. 2008 Jun 12;358(24):2573-84. doi: 10.1056/NEJMoa073121.

7.

Safety and immunogenicity of the modified adult tick-borne encephalitis vaccine FSME-IMMUN: results of two large phase 3 clinical studies.

Loew-Baselli A, Konior R, Pavlova BG, Fritsch S, Poellabauer E, Maritsch F, Harmacek P, Krammer M, Barrett PN, Ehrlich HJ; FSME-IMMUN study group.

Vaccine. 2006 Jun 12;24(24):5256-63. Epub 2006 Apr 3.

PMID:
16624457
8.

Randomized, phase II dose-finding studies of a modified tick-borne encephalitis vaccine: evaluation of safety and immunogenicity.

Ehrlich HJ, Pavlova BG, Fritsch S, Poellabauer EM, Loew-Baselli A, Obermann-Slupetzky O, Maritsch F, Cil I, Dorner F, Barrett PN.

Vaccine. 2003 Dec 12;22(2):217-23.

PMID:
14615149
9.

Experiences with a psychological help service for women following a prenatal diagnosis: results of a follow-up study.

Leithner K, Maar A, Maritsch F.

J Psychosom Obstet Gynaecol. 2002 Sep;23(3):183-92.

PMID:
12436804
10.

A randomized, controlled trial to study the efficacy and safety of C1 inhibitor concentrate in treating hereditary angioedema.

Kunschak M, Engl W, Maritsch F, Rosen FS, Eder G, Zerlauth G, Schwarz HP.

Transfusion. 1998 Jun;38(6):540-9.

PMID:
9661687
11.

[Evaluation of a community psychotherapy institution].

Jandl-Jager E, Maritsch F, Nemeskeri N, Kirchler E.

Psychother Psychosom Med Psychol. 1988 Nov;38(11):394-400. German. No abstract available.

PMID:
3237975
12.

[Patient careers I. Patient representation and motivation for participation in a catamnestic interview 5 years later].

Ringler M, Jandl-Jager E, Maritsch F.

Psychother Psychosom Med Psychol. 1983 Jul;33(4):153-7. German. No abstract available.

PMID:
6611809

Supplemental Content

Loading ...
Support Center